-
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma
Neppelenbroek, S. I. M., Geurts, Y. M., Aleman, B. M. P., Lugtenburg, P. J., Rademakers, S. E., de Weijer, R. J., Schippers, M. G. A., Ta, B. D. P., Plattel, W. J., Zijlstra, J. M., van der Maazen, R. W. M., Nijziel, M. R., Ong, F., Schimmel, E. C., Posthuma, E. F. M., Kersten, M. J., Böhmer, L. H., Muller, K., Koene, H. R. & Te Boome, L. C. J. & 5 others, , 1 Jun 2024, In: Journal of clinical oncology. 42, 16, p. 1903-1913 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
Geurts, Y. M., Neppelenbroek, S. I. M., Aleman, B. M. P., Janus, C. P. M., Krol, A. D. G., van Spronsen, D. J., Plattel, W. J., Roesink, J. M., Verschueren, K. M. S., Zijlstra, J. M., Koene, H. R., Nijziel, M. R., Schimmel, E. C., de Jongh, E., Ong, F., te Boome, L. C. J., van Rijn, R. S., Böhmer, L. H., Ta, B. D. P. & Visser, H. P. J. & 10 others, , 1 Feb 2024, In: ESMO open. 9, 2, 102248.Research output: Contribution to journal › Article* › Academic › peer-review
-
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: An emerging clinical problem
Poels, K., Neppelenbroek, S. I. M., Kersten, M. J., Antoni, M. L., Lutgens, E. & Seijkens, T. T. P., 24 Jun 2021, In: Journal for Immunotherapy of Cancer. 9, 6, e002916.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
